NCT03398889View on ClinicalTrials.gov

Intestinal Microbiome and Extremes of Atherosclerosis

CompletedOBSERVATIONAL
Enrollment

316

Participants

Timeline

Start Date

July 1, 2014

Primary Completion Date

October 15, 2016

Study Completion Date

October 15, 2016

Conditions
Gastrointestinal Microbiome, Atherosclerosis, NutrientsRenal Function
Interventions
DIAGNOSTIC_TEST

Plasma levels of metabolites

plasma levels of metabolites

BEHAVIORAL

Dietary questionnaire

Harvard food frequency questionnaire

DIAGNOSTIC_TEST

Intestinal microbiome

amplification and sequencing of 16S rRNA gene variable regions in stool samples

Trial Locations (1)

N6G 2V4

Stroke Prevention & Atherosclerosis Research Centre, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT03398889 - Intestinal Microbiome and Extremes of Atherosclerosis | Biotech Hunter | Biotech Hunter